113 related articles for article (PubMed ID: 2757844)
21. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
22. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Groves MD
Neurology; 2006 May; 66(10):1609-10; author reply 1609-10. PubMed ID: 16717241
[No Abstract] [Full Text] [Related]
23. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
24. [Polysialylated NCAM in CSF, a marker for invasive medulloblastoma].
Dubois C; Figarella-Branger D; Rougon G; Rampini C
C R Seances Soc Biol Fil; 1998; 192(2):289-96. PubMed ID: 9759372
[TBL] [Abstract][Full Text] [Related]
25. [The diagnostic value of immunoglobulin G in the cerebrospinal fluid of brain tumor patients, particularly in malignant tumors].
Onodera Y; Saitoh Y; Nagai K
Gan No Rinsho; 1987 Oct; 33(12):1402-6. PubMed ID: 3682191
[TBL] [Abstract][Full Text] [Related]
26. [Spinal leptomeningeal tumor spread disclosing a pineocytoma].
Pasquier B; Le Marc'Hadour F; Dieny A; Ciapa A; Lefrancq T; Bost F; Martal S; Micoud M; Pasquier D
Ann Pathol; 1992; 12(2):135-8. PubMed ID: 1599573
[TBL] [Abstract][Full Text] [Related]
27. Leptomeningeal carcinomatosis in a patient with metastatic prostate cancer: case report and literature review.
Cone LA; Koochek K; Henager HA; Fausel R; Gade-Andavolu R; Potts BE; Jennings LM
Surg Neurol; 2006 Apr; 65(4):372-5, discussion 375-6. PubMed ID: 16531199
[TBL] [Abstract][Full Text] [Related]
28. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
[TBL] [Abstract][Full Text] [Related]
29. [An autopsy case of leptomeningeal malignant melanoma associated with leptomeningeal dermoid cyst on the right pulvinar (author's transl)].
Miwa A; Kitagawa M; Hondo H; Washiyama K; Sugiyama Y; Kawasaki S; Fukuda M
No To Shinkei; 1981 Dec; 33(12):1187-93. PubMed ID: 7326149
[No Abstract] [Full Text] [Related]
30. Predictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast carcinoma.
Celen O; Yildirim E; Ozen N; Sonmez C
Neoplasma; 2006; 53(4):347-51. PubMed ID: 16830065
[TBL] [Abstract][Full Text] [Related]
31. [The clinical significance of sialic acid in the serum in benign and malignant disease].
Henn KH; Gressner AM
J Clin Chem Clin Biochem; 1987 Jul; 25(7):423-30. PubMed ID: 3655663
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging of leptomeningeal metastases to the spine.
Chua SL; Goh PS; Tan LK
Singapore Med J; 1993 Jun; 34(3):253-6. PubMed ID: 8266185
[TBL] [Abstract][Full Text] [Related]
33. Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis.
Rogers LR; Duchesneau PM; Nunez C; Fishleder AJ; Weick JK; Bauer LJ; Boyett JM
Neurology; 1992 Jun; 42(6):1239-41. PubMed ID: 1603352
[TBL] [Abstract][Full Text] [Related]
34. Brainstem glioma: clinical manifestations of meningeal gliomatosis.
Packer RJ; Allen J; Nielsen S; Petito C; Deck M; Jereb B
Ann Neurol; 1983 Aug; 14(2):177-82. PubMed ID: 6625534
[TBL] [Abstract][Full Text] [Related]
35. Images in neuro-oncology: brain metastases and leptomeningeal dissemination of nonseminomatous germ cell tumor.
Miranda P; Ramos A; Ricoy JR
J Neurooncol; 2005 May; 73(1):51-2. PubMed ID: 15933818
[No Abstract] [Full Text] [Related]
36. Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis.
Phillips PC; Than TT; Cork LC; Hilton J; Carson BS; Colvin OM; Grochow LB
Cancer Res; 1992 Nov; 52(22):6168-74. PubMed ID: 1423260
[TBL] [Abstract][Full Text] [Related]
37. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
[TBL] [Abstract][Full Text] [Related]
38. Malignant transformation of intracranial epidermoid cyst with leptomeningeal carcinomatosis: case report.
Hamlat A; Hua ZF; Saikali S; Egreteau J; Guegan Y
Acta Neurol Belg; 2003 Dec; 103(4):221-4. PubMed ID: 15008508
[TBL] [Abstract][Full Text] [Related]
39. Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
Chamberlain MC; Johnston SK; Glantz MJ
Arch Neurol; 2009 Jan; 66(1):74-8. PubMed ID: 19139302
[TBL] [Abstract][Full Text] [Related]
40. [Usefulness of sialic acid as a tumor marker].
Feliú J; Daimiel E; Vicente J; Martín G; García Girón C; Chacón I; González Barón M
Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
